Add this topic to your myFT Digest for news straight to your inbox
Early signs are promising but there will be limits on how much the drug companies can charge
Antibody would be one of first treatment options for patients with mild or moderate illness
Setback deals another blow to most common hypothesis about causes of the disease
Pharmaceuticals company said revenue driven by selling more drugs, not raising prices
Cheaper option was unveiled shortly before company was grilled by Congress about soaring prices
Pharma group beats expectations despite competition knocking erectile dysfunction drug sales
Amgen, Merck and Eli Lilly say Trump administration’s move infringes on free speech
Pfizer, Eli Lilly and Merck raise earnings forecasts for 2019
Animal health spin off helps pharmaceutical group raise earnings forecasts
Move comes amid persistent criticism over rising US drug prices
Deal is latest by large pharma groups seeking to bolster pipelines
The US needs a health secretary with the mettle to enact painful industry reforms
US pharmaceutical group narrows focus to prescription drugs business
Hit film about smuggling of generic drugs adds to pressure on multinationals
Duo’s tests of lanabecestat halted as primary targets ‘not likely’ to be met
If more drug trials fail, new approaches might be needed
January M&A surge prompts questions over valuations
Most of the biggest names in the field say they are committed to fighting the disease
US pharmaceuticals group seeks to refocus on prescription drugs market
Unit is world’s second largest supplier of medicines for pets and livestock
International Edition